These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1679 related articles for article (PubMed ID: 28040437)

  • 21. Effects of auriculasin on vascular endothelial growth factor (VEGF)-induced angiogenesis via regulation of VEGF receptor 2 signaling pathways in vitro and in vivo.
    Cho HD; Moon KD; Park KH; Lee YS; Seo KI
    Food Chem Toxicol; 2018 Nov; 121():612-621. PubMed ID: 30236598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling.
    Liu Y; He Y; Yang F; Cong X; Wang J; Peng S; Gao D; Wang W; Lan L; Ying X; Liu M; Chen Y; Yi Z
    Sci China Life Sci; 2017 Feb; 60(2):202-214. PubMed ID: 28194552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Melanocyte-stimulating hormone inhibits angiogenesis through attenuation of VEGF/VEGFR2 signaling pathway.
    Weng WT; Huang SC; Ma YL; Chan HH; Lin SW; Wu JC; Wu CY; Wen ZH; Wang EM; Wu CL; Tai MH
    Biochim Biophys Acta; 2014 Jun; 1840(6):1850-60. PubMed ID: 24530634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Pang X; Yi Z; Zhang X; Sung B; Qu W; Lian X; Aggarwal BB; Liu M
    Cancer Res; 2009 Jul; 69(14):5893-900. PubMed ID: 19567671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathway.
    Wu Y; He L; Zhang L; Chen J; Yi Z; Zhang J; Liu M; Pang X
    J Pharmacol Exp Ther; 2011 Nov; 339(2):403-11. PubMed ID: 21828260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trans-3,4,5,4'-tetramethoxystilbene, a resveratrol analog, potently inhibits angiogenesis in vitro and in vivo.
    Chen LK; Qiang PF; Xu QP; Zhao YH; Dai F; Zhang L
    Acta Pharmacol Sin; 2013 Sep; 34(9):1174-82. PubMed ID: 23770989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathway.
    Lin SW; Huang SC; Kuo HM; Chen CH; Ma YL; Chu TH; Bee YS; Wang EM; Wu CY; Sung PJ; Wen ZH; Wu DC; Sheu JH; Tai MH
    Mar Drugs; 2015 Feb; 13(2):861-78. PubMed ID: 25668036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
    J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells.
    Kalishwaralal K; Sheikpranbabu S; BarathManiKanth S; Haribalaganesh R; Ramkumarpandian S; Gurunathan S
    Angiogenesis; 2011 Mar; 14(1):29-45. PubMed ID: 21061058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Water extract of Cinnamomum cassia suppresses angiogenesis through inhibition of VEGF receptor 2 phosphorylation.
    Kim EC; Kim HJ; Kim TJ
    Biosci Biotechnol Biochem; 2015; 79(4):617-24. PubMed ID: 25560253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-Jun N-terminal kinase mediated VEGFR2 sustained phosphorylation is critical for VEGFA-induced angiogenesis in vitro and in vivo.
    Shen K; Ji L; Lu B; Wang Z
    Cell Biochem Biophys; 2012 Sep; 64(1):17-27. PubMed ID: 22592917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
    Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
    Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway.
    Ji L; Wu M; Li Z
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30111763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The recombinant kringle domain of urokinase plasminogen activator inhibits VEGF165-induced angiogenesis of HUVECs by suppressing VEGFR2 dimerization and subsequent signal transduction.
    Kim BM; Lee DH; Choi HJ; Lee KH; Kang SJ; Joe YA; Hong YK; Hong SH
    IUBMB Life; 2012 Mar; 64(3):259-65. PubMed ID: 22252975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
    Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Niclosamide inhibits the inflammatory and angiogenic activation of human umbilical vein endothelial cells.
    Huang M; Qiu Q; Zeng S; Xiao Y; Shi M; Zou Y; Ye Y; Liang L; Yang X; Xu H
    Inflamm Res; 2015 Dec; 64(12):1023-32. PubMed ID: 26499405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathway.
    Watari K; Nakamura M; Fukunaga Y; Furuno A; Shibata T; Kawahara A; Hosoi F; Kuwano T; Kuwano M; Ono M
    Int J Cancer; 2012 Jul; 131(2):310-21. PubMed ID: 21826646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Didymin by suppressing NF-κB activation prevents VEGF-induced angiogenesis in vitro and in vivo.
    Shukla K; Sonowal H; Saxena A; Ramana KV
    Vascul Pharmacol; 2019 Apr; 115():18-25. PubMed ID: 30634049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of Resveratrol to Vascular Endothelial Growth Factor Suppresses Angiogenesis by Inhibiting the Receptor Signaling.
    Hu WH; Duan R; Xia YT; Xiong QP; Wang HY; Chan GK; Liu SY; Dong TT; Qin QW; Tsim KW
    J Agric Food Chem; 2019 Jan; 67(4):1127-1137. PubMed ID: 30525561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 84.